Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia.
about
Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data.British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma.The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study.The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions.Inflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infectionBiopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniquesThe Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?Review article: screening and surveillance of Barrett's oesophagus: what is a cost-effective framework?Differences in genetic instability and cellular phenotype among Barrett's, cardiac, and gastric intestinal metaplasia in a Japanese population with Helicobacter pylori.Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.Barrett's Esophagus: Emerging Knowledge and Management StrategiesThe interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north ChinaUnraveling the mystery of the gastroesophageal junction: a pathologist's perspective.Barrett's esophagus and its correlation with gastroesophageal reflux in Chinese.Barrett's oesophagus--a pathologist's view.Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association SymposiumRisk of malignant progression in Barrett's esophagus patients: results from a large population-based studyThe effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.A review of the clinicopathologic characteristics of intestinal metaplasia in gastric mucosal biopsies.Columnar lined (Barrett's) esophagus: future perspectives.Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesionsDrug interactions in inflammatory bowel disease.Barrett's esophagus and cardiac intestinal metaplasia: two conditions within the same spectrum.Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review.Colonic treatments and targets: issues and opportunities.Short-Segment Barrett's Esophagus and Adenocarcinoma.The biological meaning of intestinal metaplasia of the gastroesophageal junction.Current issues in Barrett's esophagus and Barrett's-related dysplasia.Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.Inter-endoscopist agreement in diagnosis of Barrett's oesophagus.Short-segment Barrett's esophagus and cardia intestinal metaplasia: A comparative analysis.Gene expression profiling in Barrett's esophagus and cardia intestinal metaplasia: a comparative analysis using cDNA microarray.Protagonist: endoscopic surveillance of patients with Barrett's oesophagus.Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.Prevalence of Barrett's esophagus in individuals without typical symptoms of gastroesophageal reflux disease.
P2860
Q31083667-8ED66BB0-BA3F-4EA1-A417-78B6D2B07D6CQ34380645-4306CD7E-5D78-41B8-9465-BACACA321064Q34703662-BC1AFFE2-1E67-459E-A43B-DC897B250D4FQ34786281-7EC64644-5B46-4546-9ECB-17FCF09318BBQ35067345-EC8ABA10-CC83-4D76-BD2F-AED3D45D9CFBQ35147677-FC152C81-D1D9-4718-82DB-3C7215BAE2F1Q35252139-8EFE2FB5-EB24-4C93-A23D-661BF23A4D7FQ35588464-E829984F-D038-45CD-A8BA-18572E8E153CQ35595332-33777AA0-CAE8-48F8-B016-FB9A5FB85939Q35596893-C5EDBE5B-BA06-483F-B45D-56A734BDD21DQ35630069-92EA6D67-1EDE-4635-8A7E-7B6C7A292C27Q35691577-2F603646-C87D-4EC1-8A47-923F8450D11BQ35840327-EB90AC1E-2EE8-44EA-9EE8-AFC549580D6FQ35904913-1A86AC99-EB72-4F9E-9D9F-C6A65E734874Q36014649-EC0A518B-E904-43CC-8090-98E9C3C82630Q36041651-360CD287-EA8C-45A8-B984-E66DAF9D1094Q36190319-D1BBDCA0-93A1-4EA2-A839-EC03AF211309Q36249717-33A9817C-664A-43BF-83E1-81D5E4D7BF7EQ36474658-5E3ABD58-C9FB-4D32-BE62-1DD476A6A090Q36699514-E1BBB084-8328-4F9A-8DEB-46F6197FDA33Q36764087-70890E67-CE5A-4B96-B0C5-D702A1DB25D8Q36783294-4F735761-CB23-4274-A244-B8E036BDC0DEQ36860466-875EC209-3C19-480A-A7BC-D2DEF126CD1AQ36888745-F92EF4D7-20CF-441E-9B19-33860CE5A232Q36940066-EA1C9F90-B66A-427A-81DF-1E00BF1205E6Q36986372-890CDA8F-0259-4E7E-930A-B94D5BF1F552Q37030998-4B2883F4-C73C-43AC-AEA6-274EB3279231Q37144249-EAC630D3-0C20-45DE-9271-F1E708204496Q37379015-60203CAA-24BB-420D-997A-B1ABBED76DB5Q37530912-BF394150-7C25-41A2-A047-DBBB214EDE1CQ37678910-18244162-7FFB-4B0B-A7F4-C768AD7C4E96Q37756366-016D472B-5895-443B-86E6-502E0403E3F5Q38308045-64EE29FD-80E4-4643-ABBC-E1E179C8E65EQ38328606-AB5B6629-33A1-4C2D-8E6E-91951E2BFD27Q41189177-E8122B1F-B3EE-4893-A47F-972797F50265Q41544625-66609272-2514-430E-85D2-9E8681F4B2E7Q42587113-2C8E914C-3339-44C8-9D8F-BAA0282F650DQ43006178-7AECBC98-30F9-4D93-8675-21EFB6019281Q43136875-D11B0052-8D9A-47C3-86A7-AE011038FB9BQ46634446-527B62A2-A1CC-47C0-8DA4-2738CF4EDCCA
P2860
Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Relative risk of dysplasia for ...... gus and in the gastric cardia.
@ast
Relative risk of dysplasia for ...... gus and in the gastric cardia.
@en
type
label
Relative risk of dysplasia for ...... gus and in the gastric cardia.
@ast
Relative risk of dysplasia for ...... gus and in the gastric cardia.
@en
prefLabel
Relative risk of dysplasia for ...... gus and in the gastric cardia.
@ast
Relative risk of dysplasia for ...... gus and in the gastric cardia.
@en
P2093
P2860
P356
P1433
P1476
Relative risk of dysplasia for ...... gus and in the gastric cardia.
@en
P2093
P2860
P356
10.1136/GUT.46.1.9
P407
P577
2000-01-01T00:00:00Z